J Pharmacol Exp Ther 1997 Nov 01;2832:675-83.

Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes.

???displayArticle.abstract???
Because chronic exposure to nicotine and nicotinic drugs might both activate and desensitize nicotinic acetylcholine receptors (AChRs), we sought to determine whether prolonged exposure to nicotine concentrations encountered in tobacco users differentially affects electrophysiological properties of major subtypes of human neuronal nicotinic AChRs. Xenopus laevis oocytes were injected with subunit cRNAs encoding (1) homomeric alpha7 AChRs, (2) heteromeric alpha4beta2 AChRs and (3) heteromeric alpha3 AChRs formed from combinations of alpha3, beta2, beta4 and alpha5 cRNAs. Acute activation required micromolar concentrations of nicotine. Chronic exposure to submicromolar concentrations of nicotine irreversibly inactivated many alpha4beta2 AChRs and alpha7 AChRs but inhibited alpha3 AChRs much less. Thus, although alpha3 AChRs are present in the brain in much smaller amounts than are alpha4beta2 AChRs or alpha7 AChRs, alpha3 AChRs in brain and autonomic ganglia may be able to play a relatively large role in acute responses to endogenous ACh or subsequent doses of nicotine after chronic exposure to nicotine. The behavioral effects of nicotine may typically reflect the sustained inhibition of alpha4beta2 AChRs and alpha7 AChRs in combination with the residual susceptibility of alpha3 AChRs and perhaps some other AChR subtypes for acute activation. Tolerance for nicotine exhibited by tobacco users may reflect the long-term irreversible functional inactivation of alpha4beta2 AChRs and alpha7 AChRs produced by chronic exposure to nicotine.

???displayArticle.pubmedLink??? 9353385
???displayArticle.link??? J Pharmacol Exp Ther